Trial intelligence / Profile preview

Effect of Amitriptyline and Trifluoperazine on Patients with Functional Dyspepsia

TCTR20250612003Phase 3Recruiting

Sponsor
N/A
Start
Jul 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of amitriptyline and trifluoperazine in functional dyspepsia (FD), sponsored by N/A. Started Jul 2025; status: recruiting.

02

Drugs

amitriptylinetrifluoperazine
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on TCTR20250612003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250612003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call